A short post says people losing weight on drugs like Ozempic should keep an eye on common nutrient gaps, and links out to a longer list.
Recap by typeshit. Post by Facebook on Facebook.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
Mean weight loss was 1.5% to 3.2% at day 29. The cash-strapped biotech says the drug is easier on the gut and wants a partner to run phase 2.
Coverage under the national health system will come with pre-approval requirements, BMI criteria and weight loss targets patients must meet, SigmaLive reports.
Loading…